The University of Dundee Drug Discovery Unit, Scotland, has announced a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration including Alzheimer’s disease.
22 February, 2019